Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Ruple

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Journal of the American Veterinary Medical Association|October 8, 2025
Owner-reported experiences are similar for dogs experiencing euthanasia or unassisted death: evaluation of the Dog Aging Project's End of Life Survey free-text responsesJacob Ryave, Ian Kutrybala, Janice O'Brien, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Basal and Luminal Molecular Subtypes in Naturally-Occurring Canine Urothelial Carcinoma are Associated with Tumor Immune Signatures and Dog BreedBreann C Sommer, Deepika Dhawan, Audrey Ruple, et al.
Oncotarget|January 18, 2019
Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinomaNicholas M Szigetvari, Deepika Dhawan, José A Ramos-Vara, et al.
Molecular Cancer Therapeutics|August 26, 2021
Phase I/II Trial of Vemurafenib in Dogs with Naturally Occurring, <i>BRAF</i>-mutated Urothelial CarcinomaPaul Rossman, Tanja S Zabka, Audrey Ruple, et al.
Frontiers in Oncology|November 28, 2022
Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinomaDeepika Dhawan, José A Ramos-Vara, Sagar M Utturkar, et al.
Geroscience|March 4, 2025
Rationale and design of the Dog Aging Project precision cohort: a multi-omic resource for longitudinal research in geroscienceJena Prescott, Amber J Keyser, Paul Litwin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2025
Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2Nicola J Mason, Laura Selmic, Audrey Ruple, et al.
Geroscience|February 14, 2025
Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a prospective, parallel-group, double-masked, randomized, placebo-controlled, multicenter trial of rapamycin in healthy middle-aged dogs from the Dog Aging ProjectAmanda E Coleman, Kate E Creevy, Rozalyn Anderson, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Journal of the American Veterinary Medical Association|October 8, 2025
Owner-reported experiences are similar for dogs experiencing euthanasia or unassisted death: evaluation of the Dog Aging Project's End of Life Survey free-text responsesJacob Ryave, Ian Kutrybala, Janice O'Brien, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Basal and Luminal Molecular Subtypes in Naturally-Occurring Canine Urothelial Carcinoma are Associated with Tumor Immune Signatures and Dog BreedBreann C Sommer, Deepika Dhawan, Audrey Ruple, et al.
Oncotarget|January 18, 2019
Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinomaNicholas M Szigetvari, Deepika Dhawan, José A Ramos-Vara, et al.
Molecular Cancer Therapeutics|August 26, 2021
Phase I/II Trial of Vemurafenib in Dogs with Naturally Occurring, <i>BRAF</i>-mutated Urothelial CarcinomaPaul Rossman, Tanja S Zabka, Audrey Ruple, et al.
Frontiers in Oncology|November 28, 2022
Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinomaDeepika Dhawan, José A Ramos-Vara, Sagar M Utturkar, et al.
Geroscience|March 4, 2025
Rationale and design of the Dog Aging Project precision cohort: a multi-omic resource for longitudinal research in geroscienceJena Prescott, Amber J Keyser, Paul Litwin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2025
Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2Nicola J Mason, Laura Selmic, Audrey Ruple, et al.
Geroscience|February 14, 2025
Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a prospective, parallel-group, double-masked, randomized, placebo-controlled, multicenter trial of rapamycin in healthy middle-aged dogs from the Dog Aging ProjectAmanda E Coleman, Kate E Creevy, Rozalyn Anderson, et al.
Pageof 8